Related Experiment Videos
Fulminant myasthenia gravis soon after initiation of acebutolol therapy
C Confavreux1, N Charles, G Aimard
1Hôpital Neurologique, Lyon, France.
European Neurology
|January 1, 1990
Abstract:
We report the case of myasthenia gravis in a 74-year-old woman, 2 weeks after acebutolol had been introduced as the sole treatment for systemic hypertension. The disease developed at a fulminant and fatal course despite drug withdrawal. The possibilities of coincidental association between the two events, triggering of a preexisting latent myasthenia gravis or full induction of the disease by acebutolol, are discussed.